Non-nucleoside NS5B polymerase inhibitor

This page covers all Non-nucleoside NS5B polymerase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HCV NS5B RNA-dependent RNA polymerase.

Targets

HCV NS5B RNA-dependent RNA polymerase

Phase 3 pipeline (1)

• ABT-333 · AbbVie (prior sponsor, Abbott) · Virology / Hepatology
  ABT-333 is a non-nucleoside inhibitor of hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase that blocks viral replication.

Patent intelligence

• non nucleoside ns5b polymerase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates